To the full analysis
CellaVision stock: growth
CEVI.STCellaVision reported $76.1M in revenue for fiscal 2025, up 4.9% on the prior year, up 10% a year on average over up to five years.
Daily figure as of 13 Nov 2026
Revenue (Annual rate)
13.8%
per year from 2007 to 2025, per share 13.8%
Earnings (Annual rate)
25.3%
per year from 2007 to 2025, per share 25.3%
Free cash flow (Annual rate)
no data
Growth per year by period
What reaches shareholders is growth per share: buybacks lift it, new shares dilute it.
| since 2020 | since 2015 | since 2007 | |
|---|---|---|---|
| Revenue | 10.0% | 12.2% | 13.8% |
| Revenue per share | 10.0% | 12.2% | 13.8% |
| Earnings | 11.3% | 11.2% | 25.3% |
| Earnings per share | 11.4% | 11.2% | 25.3% |
| Free cash flow | 37.1% | 8.7% | no data |
| Free cash flow per share | 37.1% | 8.7% | no data |
Fiscal years at a glance
How revenue and earnings grow
- Revenue
- Earnings
- Free cash flow
Figures as a table
| Year | Revenue | Earnings | Free cash flow |
|---|---|---|---|
| 2007 | $7.48M | $263.21K | −$102.68K |
| 2008 | $10.07M | $2.51M | −$1M |
| 2009 | $10.93M | $2.78M | $949.17K |
| 2010 | $13.2M | $3.85M | $674.53K |
| 2011 | $15.58M | $1.47M | $2.62M |
| 2012 | $17M | $646.85K | $38.4K |
| 2013 | $18.03M | $1.9M | $1.55M |
| 2014 | $21.75M | $3.16M | $2.61M |
| 2015 | $24M | $5.3M | $7.9M |
| 2016 | $26.58M | $6M | $6.25M |
| 2017 | $31.02M | $6.99M | $5.9M |
| 2018 | $36.58M | $8.89M | $5.22M |
| 2019 | $46.3M | $9.94M | $10.76M |
| 2020 | $47.27M | $8.97M | $3.76M |
| 2021 | $56.71M | $12.57M | $7.56M |
| 2022 | $64.11M | $11.87M | $6.8M |
| 2023 | $67.91M | $13.07M | $11.03M |
| 2024 | $72.52M | $14.11M | $18.7M |
| 2025 | $76.1M | $15.35M | $18.22M |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Currency
- Amounts in US dollars, converted at the ECB reference rate of 12 Nov 2026 ($1 = SEK 9.9729)
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Strong, published since 7 Nov 2026 (in the score history since 22 May 2026)
- Valuation signal Fairly valued since 7 Nov 2026
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.